Shi, Y., Fan, G., Tan, R., Li, S., Sun, H., Li, R., . . . Dai, M. Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates. Nature Publishing Group.
Chicago Style (17th ed.) CitationShi, Yu-Ying, et al. Treating ICB-resistant Cancer by Inhibiting PD-L1 via DHHC3 Degradation Induced by Cell Penetrating Peptide-induced Chimera Conjugates. Nature Publishing Group.
MLA (9th ed.) CitationShi, Yu-Ying, et al. Treating ICB-resistant Cancer by Inhibiting PD-L1 via DHHC3 Degradation Induced by Cell Penetrating Peptide-induced Chimera Conjugates. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.